Talk:Amitriptyline: Difference between revisions
>M arf an oops |
>Tracer m Tracer moved page Amitriptyline to Talk:Amitriptyline: Moved to talk page |
||
Line 1: | Line 1: | ||
<!-- kenan's mum is fat --> | <!-- kenan's mum is fat --> | ||
{{SubstanceBox/Amitriptyline}}'''Amitriptyline''' (trade name '''Elavil''' or '''Vanatrip''') is a [[Antidepressants#Tricyclics|tricyclic antidepressant]] drug used to treat depression, chronic neuropathic pain and migraines. It was | {{SubstanceBox/Amitriptyline}}'''Amitriptyline''' (trade name '''Elavil''' or '''Vanatrip''') is a [[Antidepressants#Tricyclics|tricyclic antidepressant]] drug used to treat depression, chronic neuropathic pain and migraines. It was the second known antidepressant and developed by the American pharmaceutical company [https://en.wikipedia.org/wiki/Merck_%26_Co. Merck] in the late 1950s. Amitriptyline is on the WHO Model List of Essential Medicines, the most important medications needed in a basic health system. Due to the frequency and prominence of side effects, amitriptyline is generally considered a second-line medication. | ||
It is also rarely abused at strong and high doses for euphoric and sedative effects, though there is almost no information about its effects as a recreational drug | |||
==History and culture== | ==History and culture== | ||
Line 7: | Line 9: | ||
Pharmaceutical companies [https://en.wikipedia.org/wiki/Hoffmann-La_Roche Roche] and [https://en.wikipedia.org/wiki/Lundbeck Lundbeck] were also able to create patents on the drug thanks to a quirk of the patent law in the EU at the time allowing patents only on the chemical synthesis, but not on the drug itself. | Pharmaceutical companies [https://en.wikipedia.org/wiki/Hoffmann-La_Roche Roche] and [https://en.wikipedia.org/wiki/Lundbeck Lundbeck] were also able to create patents on the drug thanks to a quirk of the patent law in the EU at the time allowing patents only on the chemical synthesis, but not on the drug itself. | ||
The drug quickly surpassed its predecessor, [[imipramine]], because of its stronger anxiolytic effect and a campaign by the Merck company, raising awareness of depression as a clinical issue. Between 1998 and 2017 | The drug quickly surpassed its predecessor, [[imipramine]], because of its stronger anxiolytic effect and a campaign by the Merck company, raising awareness of depression as a clinical issue. Between 1998 and 2017 amitriptyline was the most prescribed antidepressant for 11-17 year olds in England | ||
== Chemistry == | ==Chemistry== | ||
<br /> | <br /> | ||
== Pharmacology == | ==Pharmacology== | ||
<br /> | <br /> | ||
== Subjective Effects == | ==Subjective Effects== | ||
{{Preamble/SubjectiveEffects}} | {{Preamble/SubjectiveEffects}} | ||
== Toxicity and harm potential == | ==Toxicity and harm potential== | ||
<br /> | <br /> | ||
== See also == | ==See also== | ||
<br /> | <br /> | ||
== External links == | ==External links== | ||
*[https://en.wikipedia.org/wiki/Amitriptyline Amitriptyline (Wikipedia)] | *[https://en.wikipedia.org/wiki/Amitriptyline Amitriptyline (Wikipedia)] |